文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

低收入和中等收入国家在 COVID-19 随机临床试验中的地域代表性。

Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.

机构信息

Critical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

出版信息

JAMA Netw Open. 2022 Feb 1;5(2):e220444. doi: 10.1001/jamanetworkopen.2022.0444.

DOI:10.1001/jamanetworkopen.2022.0444
PMID:35212752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8881769/
Abstract

This systematic review examines geographical representation of low- and middle-income countries in randomized clinical trials for COVID-19 compared with high-income countries.

摘要

本系统评价考察了 COVID-19 随机临床试验中低收入和中等收入国家与高收入国家的地域代表性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059a/8881769/155e867cc364/jamanetwopen-e220444-g001.jpg

相似文献

[1]
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.

JAMA Netw Open. 2022-2-1

[2]
Universal basic income and covid-19 pandemic.

BMJ. 2021-1-26

[3]
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries.

JAMA Psychiatry. 2020-12-1

[4]
COVID-19 Global health crisis.

Saudi Med J. 2021-1

[5]
Maintaining Stroke Care During the COVID-19 Pandemic in Lower- and Middle-Income Countries: World Stroke Organization Position Statement Endorsed by American Stroke Association and American Heart Association.

Stroke. 2022-3

[6]
Ethical health leadership: Lessons from low- and middle-income countries during COVID-19.

Healthc Manage Forum. 2021-1

[7]
COVID-19 and global health: Influences and implications for education and training support in low- and middle-income countries.

Anaesth Intensive Care. 2020-7

[8]
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector.

Microbes Infect. 2020

[9]
Just the facts: updates in COVID-19 therapeutics.

CJEM. 2021-5

[10]
Rethinking the Central Role of Equity in the Global Governance of Pandemic Response.

J Bioeth Inq. 2020-12

引用本文的文献

[1]
Conducting CNS trials during a public health emergency - Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper.

Neurosci Appl. 2023

[2]
The Current Landscape of Clinical Trials.

J Clin Med. 2025-4-7

[3]
Infrastructure, capabilities, and capacities required for clinical trials design and delivery: A rapid scoping review of recommendations and regulations.

Wellcome Open Res. 2025-3-6

[4]
Equitable Global Representation in Cardiovascular Guidelines and Clinical Trials: Lacunae Remain.

JACC Adv. 2024-12-26

[5]
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia.

Cancers (Basel). 2024-8-14

[6]
Understanding Heterogeneity in Acute Care Trials: Resource Availability Impacts Outcomes.

Am J Respir Crit Care Med. 2024-3-1

[7]
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.

Int J Infect Dis. 2023-7

[8]
The need for COVID-19 clinical trials in LMICs.

Front Public Health. 2023-1-9

[9]
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.

Cochrane Database Syst Rev. 2022-11-17

[10]
Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries.

Hum Vaccin Immunother. 2022-11-30

本文引用的文献

[1]
The Need for a Practical Approach to Evaluate the Effectiveness of COVID-19 Vaccines for Low- and Middle-Income Countries.

Am J Trop Med Hyg. 2021-7-16

[2]
Priorities for COVID-19 research response and preparedness in low-resource settings.

Lancet. 2021-5-22

[3]
Health inequality among different economies during early phase of COVID-19 pandemic.

J Egypt Public Health Assoc. 2021-2-17

[4]
Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges.

Intensive Care Med. 2021-2

[5]
Managing COVID-19 in Low- and Middle-Income Countries.

JAMA. 2020-4-28

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索